Reported 2 days ago
This article evaluates Pfizer Inc. (PFE) in the context of high-yield dividend stocks for 2025 and beyond. With a dividend yield of 7.72% and a history of dividend growth spanning 15 years, Pfizer remains a strong contender. It has invested significantly in oncology and reported mixed earnings in early 2025 but has committed to returning capital to shareholders. Despite its ranking as a top high-yield stock, analysts suggest exploring undervalued dividend stocks for potentially higher returns.
Source: YAHOO